Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients

Acta Oto-Laryngologica

Volumn 129, Issue 4, 2009, Pages 462-470

  Carvalho, Christine Martins ^a   Huot, Laure ^b   Charlois, Anne Laure ^b   Khalfallah, Sonia Ayari ^a   Chapuis, François ^b   Froehlich, Patrick ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Cidofovir; Database; Prognostic factors; Recurrent respiratory papillomatosis

Indexed keywords

CIDOFOVIR; ANTINEOPLASTIC AGENT; CYTOSINE; DRUG DERIVATIVE; PHOSPHONIC ACID DERIVATIVE;

ARTICLE; CARBON DIOXIDE LASER; CARCINOMA IN SITU; CHILD; CLINICAL ASSESSMENT; DATA BASE; DEBRIDEMENT; DISEASE COURSE; DISEASE REGISTRY; DYSPLASIA; ENDOSCOPY; GLOTTIS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; ONSET AGE; PAPILLOMATOSIS; PATIENT INFORMATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RECURRENT INFECTION; RESPIRATORY PAPILLOMATOSIS; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TRACHEA; VIRUS TYPING; ADULT; FACTUAL DATABASE; FEMALE; FRANCE; ISOLATION AND PURIFICATION; LARYNGOSCOPY; MALE; PAPILLOMA; REGISTER; RESPIRATORY TRACT TUMOR; TEACHING HOSPITAL; VIROLOGY; VIRUS INFECTION;

ADULT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CYTOSINE; DATABASES, FACTUAL; FEMALE; FRANCE; HOSPITALS, TEACHING; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 6; HUMANS; LARYNGOSCOPY; MALE; PAPILLOMA; PAPILLOMAVIRUS INFECTIONS; PHOSPHONIC ACIDS; PROGNOSIS; REGISTRIES; RESPIRATORY TRACT NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 66349112388     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480902737986     Document Type: Article

References (20)

1. Armstrong LR, Preston EJ, Reichert M, Phillips DL, Nisenbaum R, Todd NW, et al. Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle. Clin Infect Dis 2000;/31:/107-9.
2. Pasquale K, Wiatrack B, Woolley A, Lewis L. Microdebrider versus CO2 laser removal of recurrent respiratory pap illomas: a prospective analysis. Laryngoscope 2003;/113:/ 139-143
3. Uloza V. The course of laryngeal papillomatosis treated by endolaryngeal microsurgery. Eur Arch Otorhinolaryngol 2000;/257:/498-501.
4. Snoeck R,WellensW, Desloovere C,Van RanstM,Naesens L, De Clercq E, et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3- hydroxy-2-phosphonylmethoxypropyl)cytosine]. JMed Virol 1998;/54:/219-25.
5. Pransky SM,Magit AE, Kearns DB, Kang DR, Duncan NO. Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 1999;/125:/ 1143-1148
6. Peyton Shirley W, Wiatrak B. Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children? Int J Pediatr Otorhinolaryngol 2004;/68:/413-18. (Pubitemid 38328609)
7. Food and Drug Administration. 1996 http: //www.fda.gov/ cder/foi/adcomm/96/avdac-joint-031496-summmin-ac.pdf
8. Pudszuhn A, Welzel C, Bloching M, Neumann K. Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Eur Arch Otorhinolaryngol 2007;/264:/63-70.
9. Wemer RD, Lee JH, Hoffman HT, Robinson RA, Smith RJ. Case of progressive dysplasia concomitant with intralesional Cidofovir administration for recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2005;/114:/836-9.
10. Broekema FI, Dikkers FG. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 2008;/265:/871-9.
11. Derkay CS, Malis DJ, Zalzal G, Wiatrack BJ, Kashima HK, Coltrera M. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 1998;/108:/935-7.
12. Naiman AN, Ayari S, Nicollas R, Landry G, Colombeau B, Froehlich P. Intermediate-term and long-term results after treatment by Cidofovir and excision in juvenile laryngeal papillomatosis. Ann Otol Rhinol Laryngol 2006;/115:/667-72.
13. Buchinsky FJ, Donfack J, Derkay CS, Choi SS, Conley SF, Myer CM3rd, et al. Age of child, more than HPV type is associated with clinical course in recurrent respiratory papillomatosis. PloSONE2008;/3:/e2263.
14. Wiatrack BJ, Wiatrack DW, Broker TR, Lewis L. Recurrent Respiratory Papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 2004;/114:/1-23.
15. ReevesWC,RupareliaSS,SwansonKI,DerkayCS,MarcusA, Unger ER. National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2003;/129:/976-82.
16. Hawkes M, Campisi P, Zafar R, Punthakee X, Dupuis A, ForteV,etal. Timecourseofjuvenileonsetrecurrentrespiratory papillomatosiscausedbyhumanpapillomavirus.PediatrInfect Dis J 2008;/27:/149-53.
17. Rimell FL, Shoemaker DL, Pou AM, Jordan JA, Post JC, Ehrlich GD. Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors. Laryngoscope 1997;/107:/ 915-918
18. Rabah R, Lancaster WD, Thomas R, Gregoire L. Human papillomavirus-11- associatd recurrent respiratory papillomatosis is more aggressive than human papillomavirus- 6-associated disease. Pediatr Dev Pathol 2001;/4:/68-72.
19. Gerein V. Prognosis factors of recurrent respiratory papillomatosis spread to lower airway passages. Int J Pediatr Otorhinolaryngol 2004;/68:/1589-90.
20. Reidy PM, Dedo HH, Rabah R, Field JB, Mathog RH, Gregoire L, et al. Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope 2004;/114:/1906-9.